- Home
- DMAC vs MODV Comparison
DMAC vs MODV Comparison
Compare DMAC & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- MODV
- Stock Information
- Founded
- DMAC 2000
- MODV 1996
- Country
- DMAC United States
- MODV United States
- Employees
- DMAC N/A
- MODV N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- DMAC Health Care
- MODV Consumer Discretionary
- Exchange
- DMAC Nasdaq
- MODV Nasdaq
- Market Cap
- DMAC 172.7M
- MODV 172.6M
- IPO Year
- DMAC N/A
- MODV N/A
- Fundamental
- Price
- DMAC $4.18
- MODV $17.47
- Analyst Decision
- DMAC Strong Buy
- MODV Buy
- Analyst Count
- DMAC 3
- MODV 4
- Target Price
- DMAC $7.00
- MODV $27.25
- AVG Volume (30 Days)
- DMAC 46.2K
- MODV 230.1K
- Earning Date
- DMAC 11-13-2024
- MODV 11-06-2024
- Dividend Yield
- DMAC N/A
- MODV N/A
- EPS Growth
- DMAC N/A
- MODV N/A
- EPS
- DMAC N/A
- MODV N/A
- Revenue
- DMAC N/A
- MODV $2,787,619,000.00
- Revenue This Year
- DMAC N/A
- MODV $4.32
- Revenue Next Year
- DMAC N/A
- MODV $7.14
- P/E Ratio
- DMAC N/A
- MODV N/A
- Revenue Growth
- DMAC N/A
- MODV 3.16
- 52 Week Low
- DMAC $2.14
- MODV $11.00
- 52 Week High
- DMAC $4.95
- MODV $52.33
- Technical
- Relative Strength Index (RSI)
- DMAC 48.23
- MODV 56.72
- Support Level
- DMAC $3.96
- MODV $15.31
- Resistance Level
- DMAC $4.21
- MODV $17.50
- Average True Range (ATR)
- DMAC 0.18
- MODV 1.18
- MACD
- DMAC -0.02
- MODV 0.11
- Stochastic Oscillator
- DMAC 50.00
- MODV 62.25
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.